Bienvenido, invitado! | iniciar la sesión
US ES

Activity Stream

MoatRx
@moatrx3 weeks ago
Posted a new blog:
US PSORIASIS Competitive Intelligence
Bimekizumab hit PASI 90 in 85% of patients versus 50% for ustekinumab, resetting psoriasis's efficacy bar across six competing mechanisms. The moderate-to-severe...

Tags

Dislike 0
MoatRx
Seguidores:
bestcwlinks willybenny01 beejgordy quietsong vigilantcommunications avwanthomas audraking askbarb artisticsflix artisticflix aanderson645 arojo29 anointedhearts annrule rsacd
Recientemente clasificados:
estadísticas
Blogs: 120